C-RADS · Cólon
Sistemas/Cólon

C-RADS CT Colonography Reporting and Data System version 2023

vigente

Current CT-colonography reporting framework with separate colorectal C and extracolonic E axes. The active colorectal map is C0, C1, C2a, C2b, C3 and C4: C0 is nonassessable rather than low risk; C2a and C2b encode different findings and follow-up logic; and C4 is imaging suspicion rather than histology or pathologic stage.

Índice de referência, não é suporte à decisão clínica. O RadCommons apresenta conteúdo de referência reescrito a partir de critérios publicados e com link para a fonte primária. Confira sempre a publicação primária vigente. Não é um dispositivo médico nem substitui o julgamento clínico. O radiologista responsável pelo laudo permanece o autor e o responsável.
Escala de categorias
C0C1C2aC2bC3C4

As figuras e tabelas estão na fonte primária. Abrir a fonte. O RadCommons reescreve e cita, não reproduz figuras protegidas por direitos autorais.

Procedência e vigência

Órgão emissor
American College of Radiology
Versão
v2023 update (published and corrected 2024)
Ano
2024
Família
léxico
Tipo de lógica
flat
Modalidade
CT
Fonte primária
CT Colonography Reporting and Data System (C-RADS): Version 2023 Update · doi:10.1148/radiol.232007
Última verificação
2026-07-24
Última checagem
2026-08-12

Lógica de decisão

Forma estruturada (flat). Uma futura calculadora a lê; as categorias abaixo são a superfície legível.

Apply current C-RADS v2023 to one CTC examination, retain lesion-level facts, separate C from E, and never collapse technical inadequacy, imaging suspicion and pathology into one label.

Mostrar a lógica estruturada (JSON)
{
  "applicability": {
    "examination": "CT_colonography_screening_or_diagnostic",
    "current_release": "C-RADS_v2023",
    "classification_unit": "one_examination_with_one_overall_colorectal_C_category_and_a_separate_extracolonic_E_category",
    "prerequisites": [
      "interactive_2D_and_3D_review",
      "assessment_of_cleansing_distention_and_tagging",
      "complete_colonic_review_or_explicit_C0_limit"
    ]
  },
  "categories": [
    {
      "outcome_code": "C0",
      "state": "colorectal_assessment_not_confidently_possible",
      "triggers": [
        "technical_limitation_prevents_exclusion_of_a_polyp_10_mm_or_larger",
        "required_prior_study_not_available_for_comparison"
      ],
      "risk_state": "unassessable_not_low_risk"
    },
    {
      "outcome_code": "C1",
      "state": "normal_or_benign",
      "requirements": [
        "entire_colon_adequately_cleansed_and_distended",
        "no_polyp_6_mm_or_larger"
      ],
      "allowed_findings": [
        "diminutive_polyp_5_mm_or_smaller",
        "diverticula",
        "high_confidence_benign_myochosis_or_muscular_hypertrophy",
        "lipoma",
        "confident_residual_stool"
      ]
    },
    {
      "outcome_code": "C2a",
      "state": "one_or_two_small_polyps",
      "polyp_count": "1_or_2",
      "each_polyp_size_mm": "6_to_9_inclusive",
      "prior_code": "C2_in_the_2005_release"
    },
    {
      "outcome_code": "C2b",
      "state": "likely_benign_mass_like_diverticular_or_muscular_process",
      "findings": [
        "mass_like_diverticular_stricture",
        "moderate_or_severe_myochosis",
        "muscular_hypertrophy"
      ],
      "supportive_features": [
        "preserved_haustral_architecture",
        "no_3D_mucosal_irregularity",
        "diverticulosis",
        "lack_of_overhanging_edges_or_shoulders"
      ],
      "escalation": "if_clinical_index_of_concern_is_high_assign_C4"
    },
    {
      "outcome_code": "C3",
      "state": "polyp_or_subepithelial_lesion_requiring_colonoscopic_evaluation",
      "any_of": [
        "one_or_more_polyps_10_mm_or_larger",
        "three_or_more_polyps_each_6_to_9_mm",
        "unequivocal_interval_growth_of_a_prior_C2a_polyp",
        "subepithelial_lesion_10_mm_or_larger"
      ]
    },
    {
      "outcome_code": "C4",
      "state": "likely_malignant",
      "any_of": [
        "polypoid_mass_30_mm_or_larger",
        "malignant_appearing_mass_at_any_size"
      ]
    }
  ],
  "assignment_algorithm": [
    {
      "step": 1,
      "rule": "Assess cleansing, distention, tagging and segmental visibility; assign C0 when a confident colorectal interpretation is impossible or a required prior is missing."
    },
    {
      "step": 2,
      "rule": "Measure every reportable lesion, count 6-to-9-mm polyps, characterize morphology and reader confidence, and compare with priors using the same lesion."
    },
    {
      "step": 3,
      "rule": "Apply C4 before C3, then C2b or C2a, then C1, according to the most consequential colorectal finding; retain every raw lesion descriptor."
    },
    {
      "step": 4,
      "rule": "Assign and report the extracolonic E category independently; never use an E finding to replace the colorectal C category."
    }
  ],
  "measurement_and_reporting_protocol": {
    "reportable_polyp_threshold_mm": 6,
    "diminutive_rule": "Polyps 5 mm or smaller are generally nonreportable under the CTC framework, but technical or clinical context must not be silently discarded.",
    "size_rule": "Use the single largest diameter after 2D and 3D pitfall review; for a pedunculated polyp measure the head and exclude the stalk.",
    "required_lesion_fields": [
      "largest_diameter_mm",
      "measurement_method_and_series_or_image",
      "colon_segment_and_proximal_mid_or_distal_location",
      "sessile_pedunculated_or_nonpolypoid_morphology",
      "number",
      "reader_confidence_when_relevant"
    ],
    "location_rule": "Use rectum, sigmoid, descending, transverse, ascending or cecum; avoid flexure labels and colonoscope-distance crosswalks."
  },
  "decisive_boundaries": {
    "C0_versus_C2b": "A truly nondiagnostic collapsed or poorly prepared segment that cannot exclude a lesion of at least 10 mm is C0; a mass-like but likely benign diverticular or muscular segment with interpretable morphology is C2b.",
    "C2a_versus_C3_by_count": "One or two 6-to-9-mm polyps are C2a; three or more in that size band are C3.",
    "C2a_versus_C3_by_size": "Nine millimeters remains C2a when count permits; 10 mm is C3.",
    "C3_versus_C4": "A polyp or subepithelial lesion at least 10 mm is C3 unless it is a polypoid mass at least 30 mm or otherwise malignant appearing, which is C4."
  },
  "risk_interpretation": {
    "histology_limit": "CTC cannot determine dysplasia or histology; a C category is not a pathology result.",
    "C0_limit": "C0 supplies no neoplasia risk estimate because the colon is not adequately assessable.",
    "C2a_cohort_context": "Published surveillance cohorts found growth in 22 to 35 percent by 3 years and complete resolution in about 10 to 14 percent; these are cohort observations, not a probability for this patient's lesion.",
    "C3_context": "Polyps at least 1 cm have a reported 10 to 25 percent likelihood of high-grade dysplasia or carcinoma, varying with size; do not convert the range into individual certainty.",
    "C4_limit": "C4 means likely malignant on imaging, not proven cancer, TNM stage, resectability or prognosis."
  },
  "management_boundary": {
    "C0": "Repeat or complete CTC when visualization is inadequate, consider an alternative screening test, or amend the report when the missing prior becomes available.",
    "C1": "Routine CTC screening at 5 to 10 years, with any shorter interval justified by the full clinical and colonic context.",
    "C2a": "Repeat CTC in 3 years versus optional colonoscopy according to age, comorbidity, preference, local practice and confidence; unequivocal growth moves to C3.",
    "C2b": "High-confidence benign morphology may return at 5 years; lesser confidence supports 3 years or less; high concern is C4 with endoscopic evaluation.",
    "C3": "Recommend colonoscopic polypectomy; if it cannot be performed, CTC within 1 year or surgical referral may be appropriate according to anatomy, age and comorbidity.",
    "C4": "Recommend surgical and/or oncologic consultation with or without preoperative colonoscopic biopsy; do not infer a definitive operation from C4 alone."
  },
  "system_collision_boundary": {
    "legacy_C2": "The 2005 C2 code is retired in the current API. Use C2a for one or two 6-to-9-mm polyps and C2b for the new likely benign mass-like diverticular category.",
    "extracolonic_E_axis": "C and E are parallel outputs. In v2023, E1 and E2 are combined as E1/E2; E0 remains optional.",
    "optical_colonoscopy": "CTC size and segment descriptors must not be represented as histology or exact colonoscope distance."
  },
  "agent_output_contract": [
    "State C-RADS v2023 and whether the examination is screening or diagnostic.",
    "Report adequacy of cleansing, distention and tagging before assigning the C category.",
    "List each reportable lesion with size, method, segment, morphology, count and confidence; preserve the decisive lesion for the overall category.",
    "Return the active C code, the exact triggered rule, the linked follow-up options and patient-context qualifiers.",
    "Return the separate E category when available and never emit legacy C2 as a current result.",
    "Keep imaging suspicion, histology, cancer stage and individualized risk as separate facts."
  ],
  "missing_input_behavior": [
    "If adequacy is unknown, do not default to C1; return C-RADS_not_final and request cleansing, distention, tagging and segmental visibility.",
    "If a polyp size straddles 9 and 10 mm, preserve the measurement uncertainty and return C2a versus C3 rather than rounding silently.",
    "If the number of 6-to-9-mm polyps is incomplete, do not choose between C2a and C3.",
    "If a mass-like diverticular segment cannot be distinguished from malignant morphology, return C2b versus C4 with the missing features and recommend the appropriate resolving evaluation.",
    "If only C2 is supplied, identify it as legacy/ambiguous and request whether the intended current code is C2a or C2b."
  ],
  "supporting_sources": [
    {
      "role": "current_primary_release",
      "citation": "Yee et al. Radiology. 2024;310:e232007",
      "doi": "10.1148/radiol.232007"
    },
    {
      "role": "original_lineage",
      "citation": "Zalis et al. Radiology. 2005;236:3-9",
      "doi": "10.1148/radiol.2361041926"
    },
    {
      "role": "official_release_index",
      "citation": "American College of Radiology C-RADS current releases",
      "url": "https://cs.acr.org/Clinical-Resources/Reporting-and-Data-Systems/C-Rads"
    }
  ],
  "source_locator": "Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and sections Reporting, Pitfalls of Lesion Measurement, Classification and Suggested Follow-up of Colonic Lesions, and Reporting of Extracolonic Findings; ACR C-RADS v2023 Summary of Changes."
}

Categorias num relance

Cat.SignificadoCondutaRiscoFonte
C0
Inadequate examination or comparison pending
Assign C0 when a confident colorectal interpretation is not possible because a technical limitation prevents exclusion of a polyp 10 mm or larger, such as complete segmental collapse, insufficient insufflation or inadequate cleansing, or when a prior study required for comparison is unavailable. A mass-like but interpretable likely benign diverticular segment belongs in C2b rather than C0.
Repeat or complete the CT colonography when visualization is inadequate, consider an alternative colorectal screening test, or amend the report after the required prior examination becomes available. State the exact nonassessable segment and limitation rather than treating C0 as a negative examination.C0 does not estimate colorectal-neoplasia risk: the relevant colon is not adequately assessable, so an important lesion has not been excluded. It must never be translated into low risk, benignity or a routine negative-screen interval.
Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and Category C0 section; lines describing the >=10-mm exclusion limit, missing priors, C2b distinction and repeat/alternative/addendum options.
C1
Normal colon or benign lesion
Assign C1 only when the entire colon is adequately cleansed and distended and no polyp measures 6 mm or larger. The category may include a normal colon, diminutive nonreportable polyps 5 mm or smaller, diverticula, confidently benign myochosis or muscular hypertrophy, lipoma, and confidently characterized residual fecal material.
Continue routine CT-colonography screening at a 5- to 10-year interval. Any decision to shorten the interval should be justified by the complete clinical and colonic context, such as extensive diverticulosis or inflammatory change, rather than by the C1 label alone.C1 denotes no colorectal abnormality that increases carcinoma risk in the setting of regular screening, but it is not zero lifetime risk and does not negate interval symptoms or future screening. The classification also does not supply an individualized cancer probability.
Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and Category C1 section; adequate whole-colon requirement, <6-mm boundary, benign examples and 5-10-year screening recommendation.
C2a
One or two 6-9 mm polyps
Assign current C2a, formerly C2, when the examination contains one or two colonic polyps and each measures 6-9 mm inclusive. Record each lesion's largest diameter, segment, morphology, measurement method and confidence; unequivocal interval growth at surveillance changes the examination to C3.
Recommend repeat CT colonography in 3 years to assess growth versus optional colonoscopy with polypectomy, using patient age, comorbidities, preferences, reader confidence and local practice to choose the pathway. Low confidence can justify a shorter interval; demonstrated growth is managed as C3.In cited surveillance series, 22%-35% of 6-9-mm polyps progressed within 3 years and about 10%-14% resolved. These are cohort observations, not this lesion's probability; CT colonography cannot determine dysplasia or histology from the C2a label.
Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and Subcategory C2a section; one-or-two count, 6-9-mm range, 22%-35% growth, 10%-14% resolution and 3-year-versus-colonoscopy guidance.
C2b
Likely benign mass-like diverticular or muscular lesion
Assign C2b to a soft-tissue mass or mass-like colonic area that is likely benign, including moderate or severe diverticular myochosis, muscular hypertrophy or a stricture in which malignancy is not entirely excluded. Preserved haustra, absent 3D mucosal irregularity, diverticulosis and lack of overhanging shoulders support this category.
When benignity is highly likely, suggest routine CT-colonography follow-up at 5 years. When confidence is lower, use a shortened interval of 3 years or less according to context. If concern for malignancy is high, classify the lesion as C4 and recommend flexible sigmoidoscopy or colonoscopy rather than retaining C2b.C2b expresses likely benign morphology with residual diagnostic uncertainty; it is not a numerical malignancy-risk band or histologic diagnosis. Risk depends on the complete morphology, positional change, prior stability, symptoms and clinical context, so uncertainty and confidence must be explicit.
Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and Subcategory C2b section including Figures 5-6; morphologic features, prior comparison, 5-year/<=3-year follow-up and C4 escalation.
C3
Polyp, multiplicity, growth or subepithelial lesion requiring colonoscopy
Assign C3 for one or more polyps measuring at least 10 mm, three or more polyps each measuring 6-9 mm, unequivocal interval growth of a prior C2a polyp, or a suspected subepithelial lesion measuring at least 10 mm. Preserve which branch triggered the overall category.
Recommend colonoscopic polypectomy. If colonoscopic removal cannot be performed because of distal narrowing or severe tortuosity, short-interval CT colonography within 1 year or surgical referral may be appropriate according to patient age, comorbidities, anatomy and lesion features.Polyps at least 1 cm have a reported 10%-25% likelihood of high-grade dysplasia or carcinoma, with risk increasing with size. This source range is population context rather than an individual prediction, and C3 does not prove advanced histology or cancer.
Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and Category C3 section; size, multiplicity, growth, subepithelial-lesion branches, 10%-25% range and colonoscopy/alternative guidance.
C4
Polypoid mass at least 30 mm or malignant-appearing mass
Assign C4 for a polypoid soft-tissue mass measuring at least 30 mm or for a malignant-appearing colonic mass. Describe length, morphology, location, obstruction or narrowing, synchronous lesions, nodes and possible distant disease when technically assessable rather than replacing those findings with the code.
Recommend surgical and/or oncologic consultation, with or without preoperative colonoscopic biopsy. Intravenous-contrast CT colonography may contribute to staging, but the C4 label alone does not select an operation, establish resectability or replace tissue diagnosis and formal staging.C4 represents high imaging suspicion for malignancy, not histologic confirmation, TNM stage, operability or an individualized prognosis. A benign final diagnosis remains possible, so the report must preserve uncertainty and the evidence supporting the malignant appearance.
Yee et al. Radiology 2024, DOI 10.1148/radiol.232007, Table 2 and Category C4 section; >=30-mm polypoid-mass or malignant-appearance definition and surgical/oncologic consultation with optional biopsy.

Histórico de versões

DataEventoDetalheSituação
2024-01-30revisedC-RADS v2023 became the current corrected release: prior C2 was renamed C2a, new C2b was added for likely benign mass-like diverticular strictures, and the extracolonic E1 and E2 categories were combined as E1/E2. evidênciaconfirmado
2005-07-01publishedC-RADS consensus proposal published.confirmado
Quickstart da APIGET /api/v1/systems/c-radsaberto
curl -s "https://radcommons.laudos.ai/api/v1/systems/c-rads"
Ver documentação completa